Prev：Bioactive ROS-Responsive Nanotherapeutics Attenuate Intermittent Hypoxia-Induced Cognitive Impairment via NRF2/KEAP1/HO-1 Signaling.(A23620-4)
Next：Biodegradation of aflatoxin B1 by a novel mined aldo–keto reductase from Meyerozyma guilliermondii AF01.(ABT2051-3.4)
